—
Richemont: Considered a hot candidate for inclusion in the highly regarded Stoxx Europe 50 Index. More on the topic at 12.30 p.m. in my column.
Evolva: Veraison is investing in a private placement with a good 6pc. Acquires just under 64 million newly created shares at CHF 0.1176 each. A generous discount to the trade-weighted average price of the last few days. CFO Carsten Däweritz resigns. ZKB remains for MARKET WEIGHTS.
Ascom: Wins contract for software solutions from Italy.
Bossard: UBS goes to SELL (neutral) up to CHF 269 (280). Share is no longer undervalued. Hopes for future margin improvements seem exaggerated.
Bystronic: In the run-up to today’s Investor Day, confirms both this year’s growth and margin targets as well as the previous medium-term targets. ZKB shares still a purchase with OVERWEIGHT.
Calida: Research Partners increase to 53.50 (52.50) Fr. Go but at the same time to HOLD (Buy). New dividend policy reduces the risk of overinvestment.
dormakaba: Company boss Sabrina Soussan leaves the company after a few months. Moves to the top of a large international corporation. Quite a blow for her previous employer. Vontobel is appalled. But remains for HOLD up to 700 CHF.
Forbo: Research Partners go to BUY (hold) up to CHF 2100. Buyback offer for own shares shows confidence.
Givaudan: JP Morgan increases to 4200 (4100) Fr. with NEUTRAL. Warns of slowing growth in the coming year. Bank’s own earnings estimates are reduced by up to 5pc.
Idorsia: Research Partners go to BUY (Hold) to 20 (22) Fr. Upcoming US approval decision for sleeping pill daridorexant a possible price driver.
Molecular Partners: Covid-19 active ingredient Ensovibep also shows activity in the test tube against new South Africa variant.
Nestle: JP Morgan shares a purchase with OVERWEIGHT up to CHF 145 (135) Fr. Expect innovation-driven market share gains and strong growth in the coffee and pet food business.
Swatch Group: Barclays increases to 386 (363) Fr. with OVERWEIGHT. Is fundamentally optimistic about European luxury goods stocks.
Swisscom: Wins the cellular network test ahead of rivals Sunrise UPC and Salt. Still “the best network in Switzerland”.
Swiss Life: Citigroup wants to know, is for BUY until 571.20 (529.60) Fr. With the adjustments, takes into account the positive interim report and the new medium-term targets.
Vifor: Long-time CFO Colin Bond is leaving the company at the end of the year. The search for a successor has begun. Did Bond catch his employer “contre pied”?
Derivatives: Conspicuous sales in the knock-out calls SSMBRV on the SMI as SDABLV on the DAX.
–
